Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Two clinical studies published in the New England Journal of Medicine with an accompanying editorial suggest that the novel agent ibrutinib shows real potential as a safe, effective, targeted treatment for adults with chronic lymphocytic leukemia (CLL) and for patients with mantle cell lymphoma (MCL).
Hey, check out all the research scientist jobs. Post your resume today!
